Advertisement

Clinical Trials Are Crucial to Advance MPN Treatment

For lesser-known hematologic malignancies, such as myeloproliferative neoplasms, it is vital that ongoing clinical trials continue to investigate the tolerability and efficacy of novel regimens for the field to continue moving forward. 

 Cure